Rybelsus (semaglutide) is used to improve blood sugar control in adults with type 2 diabetes. Rybelsus is a GLP-1 Agonist, which works by increasing insulin release and reducing appetite. The most common form of Rybelsus is a 7mg tablet. It's also available in 3mg and 14mg tablets. There are currently no generic alternatives for Rybelsus. It is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower.

With the Patient Assistance Program from Novo Nordisk, you can receive your medication at no cost.